期刊文献+

急性脑梗死并高血压患者Lp(a),PAI-1水平的变化及临床意义 被引量:1

The Change of Blood Lipoprotein(a) and Plasminogen Activator Level in Patients With Acute Cerebral Infarction Accompanied with Hypertension and Its Clinical Significance
下载PDF
导出
摘要 目的 探讨急性脑梗死并高血压患者血清脂蛋白(a)(Lp(a))、纤溶酶原激活物抑制物-1(PAI-1)水平的变化及临床意义.方法 选择急性脑梗死并高血压患者54例,单纯急性脑梗死患者42例.均行经颅彩色多普勒(TCD) 、头颅MRI及MRA检查.选择30例健康体检者为对照组.检测所有患者血清Lp(a)、PAI-1水平,比较不同脑动脉供应系统和不同血管狭窄程度、不同梗死面积患者血清Lp(a)、PAI-1水平变化.结果 ①单纯急性脑梗死组Lp(a),PAI-1水平显著高于对照组,合并高血压组高于单纯急性脑梗死组,差异均有统计学意义(P〈0.01);Lp(a)与PAI-1活性显著正相关(r=0.75,P〈0.01).②不同梗死面积脑梗死患者组间Lp(a)水平呈现大梗塞灶〉小梗塞灶〉腔隙性梗塞的特点,差异具有统计学意义(P〈0.05).③动脉狭窄以颈内动脉系统发生率最高(70.6%),颈内动脉系统Lp(a)水平与椎基底动脉系统相比,差异无统计学意义(P〉0.05).④多发脑动脉狭窄患者Lp(a)水平高于单支动脉狭窄患者(P〈0.05).结论 Lp(a),PAI-1与高血压对急性脑梗死的发生具有协同作用.Lp(a),PAI-1作为急性脑梗死的危险因素,可预测患者的梗塞面积和颅内血管梗阻的严重程度. Objective To study the change of lipoprotein(a) (Lp(a) ) and PAI-1 in patients with acute cerebral infarction accompanied with hypertension. Methods The subjects were divided into three groups: cerebral infarction and hypertension group(44 cases) , cerebral infarction group(42 cases) and the control group(30 healthy people). The patients in the first two groups underwent TCD, MRI and MRA examination. For all patients,the concentration of plasma Lp(a) and PAl-1 were measured. Results (1)The plasma Lp(a) and PAI-I level in acute cerebral infarction group were higher than that of the control group ( P 〈 0.01) , and the level in acute cerebral infarction with hypertension group was higher than without hypertension group. The expression of PL( a) has positive correlation with that of PAI-1. (2)With the ischemic area increasing, PL(a) concentration increased significantly (P 〈 0.05). (3)There was no conspicuous change( P 〉 0.05) in PL (a) concentration between internal carotid artery system and basilar 'artery system. (4)The plasma Lp(a) level was higher in multiple stenosis than that in single stenosis ( P 〈 0.05 ). Conclusions Lp ( a ) , PAI-1 and hypertension have joint action on cerebral infarction. The level of Lp (a) and PAI-1 could be used as the risk factors for acute cerebral infarction.
出处 《潍坊医学院学报》 2010年第1期29-31,共3页 Acta Academiae Medicinae Weifang
关键词 脑梗死 脂蛋白(a) 高血压 危险因素 Acute cerebral infarction Lipoprotein( a ) Hypertension Risk factor
  • 相关文献

参考文献10

  • 1Yamada I,Nakagawa T,Matsushima Y,et al.High-resolution turbo magnetic resonance angiography for diagnosis of Moyamoya disease[J].Stroke,2001,32(9):1825-1831.
  • 2Demchuk AM,Christou L,Wein TH,et al.Accuracy and criteria for localizing arterial occlusion with transcranial Doppler[J].Neurolmaging,2000,10(1):1-12.
  • 3Bang OY,Cho JH,Han BI.Transcranial Doppler findings in middle cerebral arterial occlusive disease in relation to degree of stenosis and presence of concomitant stenoses[J].J Clin Ultrasound,2003,31:142-151.
  • 4贺艳丽,周新.脂蛋白(a)致动脉粥样硬化作用机制研究进展[J].中国动脉硬化杂志,2002,10(1):80-82. 被引量:18
  • 5Sun L,Li ZH.Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese[J].Stroke,2003,34(7):1617-1622.
  • 6张华,张茁.老年脑梗死非急性期血清脂蛋白(a)和血浆纤维蛋白原含量的研究[J].中华老年心脑血管病杂志,2006,8(8):543-545. 被引量:18
  • 7Etingin OR,Hajiar DP,Hajiar KA,et al.Lipoprotein(a) regulates plasminogen activator inhibitor 1 expression in endothelial cells:a potential mechanism in thrombogenesis[J].J Biol Chem,1991,266:2459-2465.
  • 8Thierry S,Stéphane L,Véronique B,et al.Effect of individual plasma lipoprotein(a) variation in vivo on its competition with plasminogen for fibrin and cell binding[J].Arterioscler Thromb Vasc Biol,2000,20:575-584.
  • 9史怀璋,李斗,李慎茂,凌锋.经DSA分析1000例缺血性脑血管病华人患者的病因特点[J].中国脑血管病杂志,2005,2(10):437-440. 被引量:93
  • 10Arenillas JF,Molina CA,Chacon P,et al.High lipoprotein(a),diabetes,and the extent of symptomatic intracranial atherosclerosis[J].Neurology,2004,63(1):27-32.

二级参考文献45

  • 1孙慧,路方红,田奇,吴凡,赵颖馨,张大鹏,商青,张薇.老年高血压患者β-纤维蛋白原-455G/A基因多态性研究[J].中华老年医学杂志,2004,23(6):365-368. 被引量:3
  • 2冯烈,徐安定,李洁.经颅多普勒超声对糖尿病患者脑血管病变的诊断价值[J].中华内分泌代谢杂志,1994,10(2):86-88. 被引量:116
  • 3[1]Wong KS. Is the measurement of cerebral microembolic signals a good surrogate marker for evaluating the efficacy of antiplatelet agents in the prevention of stroke.? Eur Neurol,2005, 53: 132-139.
  • 4[2]Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke, 1995, 26: 14-20.
  • 5[3]Frey J, Jahnke H, Bulfinch E. Difference in stroke between White, Hispanic and Native American patients.Stroke, 1998, 29: 29-33.
  • 6[4]Feldmann E, Daneault N, Kwan E, et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology, 1990, 47: 1080-1084.
  • 7[6]Huang YN, Gao S, Huang Y, et al. Vascular lesion in Chinese patients with transient ischemic attacks. Neurology,1997, 48: 524-525.
  • 8[7]Wong KS, Gao S, Lam W, et al. A pilot study of microembolic signals in patients with middle cerebral artery stenosis. J Neuroimaging, 2001, 11: 137-140.
  • 9[8]Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta analysis. BMJ, 2002, 325: 73-74.
  • 10[9]Smith C J, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol, 2004, 15: 2.

共引文献123

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部